Schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: Intervention group: The drug used is l-carnitine 1000 mg, which is given to the intervention group daily for eight weeks, which is completely similar to the placebo drug in terms of w
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Not having severe major depression based on Beck Depression Test (BECK Total score<29 have received psychiatric drugs with a fixed dose during the last 3 months. be treated with one of the second generation antipsychotic drugs
Exclusion criteria
Exclusion criteria: Presence of another diagnosis based on DSM-5 Intellectual disability Received ECT in the past 2 months History of substance and drug use except nicotine and caffeine History of seizures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of positive and negative symptoms in the PANSS test. Timepoint: The beginning of the study, the end of the fourth week, the end of the eighth week. Method of measurement: Clinical interview based on PANSS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolic syndrome. Timepoint: The beginning and end of the study. Method of measurement: Measurement of height and weight, blood pressure and waist circumference through clinical examination and measurement of triglycerides and cholesterol through paraclinics. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarges Shamsalizadeh
Sanandaj University of Medical Sciences
Outcome results
None listed